Executive Viewpoints Debate: What Will it Take to Make the Use of AI/ML Tools Scalable?

09:00 AM - 09:40 AM
  • How do you translate AI/ML technology into patient impact
    • Better treatments
    • Higher quality outcomes
    • Less adverse effect
  • Streamlining processes enterprise-wide
Dimitris K. Agrafiotis, PhD, Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Niven R. Narain, Ph.D, Co-Founder, President & CEO, BERG
Andrew Radin, CEO & Co-Founder, twoXAR Pharmaceuticals
/* */